Exploring trends in life-extending research and technology and the potential for monetization. Life-extending technologies and research are evolving exponentially, from induced pluripotent stem cells (IPS), pharmacogenomics and embedded technologies to naturally derived alternative therapies and holistic approaches.
In this climate, investors and consumers are left to perform high-stakes due diligence that can influence both the financial success of a company and also one’s individual health.
Join us for an event that brings together both internationally renowned researchers and leading life science investors for a conversation that explores the fascinating field of life extension, its potential for monetization and role in challenging humanity’s greatest adversary, mortality itself.
5:30 – 6:00pm: Registration & Networking
6:00 – 8:00pm: Program
8:00 – 9:00pm: After-party & Networking
Carol Massar, Co-host of "Taking Stock” on Bloomberg Radio, Chief National Correspondent for Bloomberg Television
- Sanjiv Chopra, Professor of Medicine at Harvard Medical School
- Aubrey de Grey, Chief Science Officer & Co-founder of the SENS Research Foundation
- George Q. Daley, Harvard University, HHMI and Children’s Hospital Boston
- Marian Nakada, Vice President Venture Investments, Johnson & Johnson Innovation
- Amy Schulman, Partner, Polaris Partners & CEO of Arsia Therapeutics
For more information and to register: http://www.mitforumcambridge.org/events/lifespan/
Note: BPMA members are invited to use the discount code MITEF-BPMA to receive $25 off of the $45 MITEF non-member price.
The Innovation Series is the banner program offering of the MITEF Cambridge chapter, with a goal to inform, connect, and inspire innovators. Typical event attendance ranges between 100 and 200, comprising students, startup founders, corporate executives, investors, academics, service providers, and other interested parties.